Scott Krause

3.0k total citations
21 papers, 2.3k citations indexed

About

Scott Krause is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Scott Krause has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Scott Krause's work include Hormonal Regulation and Hypertension (15 papers), Blood Pressure and Hypertension Studies (14 papers) and Sodium Intake and Health (4 papers). Scott Krause is often cited by papers focused on Hormonal Regulation and Hypertension (15 papers), Blood Pressure and Hypertension Studies (14 papers) and Sodium Intake and Health (4 papers). Scott Krause collaborates with scholars based in United States, Spain and United Kingdom. Scott Krause's co-authors include Barbara Roniker, Gordon H. Williams, Jay H. Kleiman, Robert Weiss, M H Weinberger, William B. White, Myron H. Weinberger, Murray Epstein, Roland Willenbrock and Bertram Pitt and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Scott Krause

21 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Krause United States 15 1.9k 1.3k 655 444 394 21 2.3k
Yoh Miyashita Japan 29 812 0.4× 1.3k 1.0× 883 1.3× 232 0.5× 276 0.7× 62 2.4k
Joel Neutel United States 20 554 0.3× 1.1k 0.9× 518 0.8× 203 0.5× 215 0.5× 48 1.9k
Christina Nowack Germany 18 3.3k 1.8× 1.8k 1.4× 773 1.2× 1.2k 2.6× 1.0k 2.6× 25 4.5k
Patrick Schloemer United States 9 1.3k 0.7× 684 0.5× 316 0.5× 388 0.9× 332 0.8× 22 2.0k
Akemi Katsurada United States 21 788 0.4× 910 0.7× 176 0.3× 113 0.3× 294 0.7× 36 1.4k
Robin Mukherjee United States 11 879 0.5× 1.2k 0.9× 1.0k 1.6× 314 0.7× 172 0.4× 16 2.1k
George L. Bakris United States 5 1.3k 0.7× 606 0.5× 301 0.5× 369 0.8× 325 0.8× 11 1.8k
Takamitsu Nakano Japan 23 1.3k 0.7× 710 0.5× 848 1.3× 109 0.2× 315 0.8× 50 2.2k
Andrei Breazna United States 22 998 0.5× 827 0.6× 1.6k 2.5× 167 0.4× 174 0.4× 30 2.7k
R. S. Elkeles United Kingdom 23 881 0.5× 481 0.4× 589 0.9× 118 0.3× 503 1.3× 72 1.9k

Countries citing papers authored by Scott Krause

Since Specialization
Citations

This map shows the geographic impact of Scott Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Krause more than expected).

Fields of papers citing papers by Scott Krause

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Krause. The network helps show where Scott Krause may publish in the future.

Co-authorship network of co-authors of Scott Krause

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Krause. A scholar is included among the top collaborators of Scott Krause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Krause. Scott Krause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Ping, et al.. (2011). Abstract P59: Aspirin Improves the Impact of Niacin-Associated Flushing on Quality of Life Measures. Circulation Cardiovascular Quality and Outcomes. 4(suppl_1). 1 indexed citations
3.
Tóth, Peter P., William Insull, Robert J. Padley, et al.. (2010). Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy. Vascular Health and Risk Management. 6. 1065–1065. 9 indexed citations
4.
Kawata, Ariane K., Dennis A. Revicki, Roopal Thakkar, et al.. (2009). Flushing ASsessment Tool (FAST©). Clinical Drug Investigation. 29(4). 215–229. 18 indexed citations
5.
Thakkar, Roopal, Moti L. Kashyap, Andrew Lewin, et al.. (2009). Acetylsalicylic Acid Reduces Niacin Extended-Release-Induced Flushing in Patients with Dyslipidemia. American Journal of Cardiovascular Drugs. 9(2). 69–79. 18 indexed citations
6.
Epstein, Murray, Gordon H. Williams, Myron H. Weinberger, et al.. (2006). Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes. Clinical Journal of the American Society of Nephrology. 1(5). 940–951. 353 indexed citations
7.
Weinberger, Myron H., William B. White, Luís M. Ruilope, et al.. (2005). Effects of eplerenone versus losartan in patients with low-renin hypertension. American Heart Journal. 150(3). 426–433. 87 indexed citations
8.
Williams, Gordon H., Ellen Burgess, R. Kolloch, et al.. (2004). Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. The American Journal of Cardiology. 93(8). 990–996. 135 indexed citations
9.
White, William B., et al.. (2003). Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. The American Journal of Cardiology. 92(1). 38–42. 87 indexed citations
10.
Burgess, Ellen, Suzanne Oparil, Jay H. Kleiman, et al.. (2003). Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension. Clinical Therapeutics. 25(9). 2388–2404. 57 indexed citations
11.
Flack, John M., Suzanne Oparil, J. Howard Pratt, et al.. (2003). Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. Journal of the American College of Cardiology. 41(7). 1148–1155. 183 indexed citations
12.
Prisant, L. Michael, Henry Krum, Barbara Roniker, et al.. (2003). Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add‐On Therapy?. The Journal of Clinical Pharmacology. 43(11). 1203–1210. 23 indexed citations
13.
White, William B., et al.. (2003). Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension. Hypertension. 41(5). 1021–1026. 237 indexed citations
14.
Hollenberg, Norman K., Gordon H. Williams, Richard B. Anderson, et al.. (2003). Symptoms and the Distress They Cause. Archives of Internal Medicine. 163(13). 1543–1543. 35 indexed citations
15.
Pitt, Bertram, Nathaniel Reichek, Roland Willenbrock, et al.. (2003). Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy. Circulation. 108(15). 1831–1838. 480 indexed citations
16.
Krum, Henry, Richard D. Gordon, H Nolly, et al.. (2002). Co-Administration of Eplerenone with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin II Antagonist in Patients with Mild to Moderate Hypertension. Japanese Circulation Journal-english Edition. 66. 561. 6 indexed citations
17.
Pitt, Bertram, Vivencio Barrios, Barbara Roniker, et al.. (2002). Efficacy and Safety of Eplerenone Compared to Enalapril in Left Ventricular Hypertrophy. Japanese Circulation Journal-english Edition. 66. 139. 1 indexed citations
18.
Weinberger, M H, Barbara Roniker, Scott Krause, & Robert Weiss. (2002). Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. American Journal of Hypertension. 15(8). 709–716. 307 indexed citations
19.
Epstein, Murray, et al.. (2002). Eplerenone reduces proteinuria in type II diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction. Journal of the American College of Cardiology. 39. 249–249. 32 indexed citations
20.
Krum, Henry, H Nolly, Weizhong He, et al.. (2002). Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients. Hypertension. 40(2). 117–123. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoh Miyashita Breakdown of academic impact, for papers by Joel Neutel Breakdown of academic impact, for papers by Christina Nowack Breakdown of academic impact, for papers by Patrick Schloemer Breakdown of academic impact, for papers by Akemi Katsurada Breakdown of academic impact, for papers by Robin Mukherjee Breakdown of academic impact, for papers by George L. Bakris Breakdown of academic impact, for papers by Takamitsu Nakano Breakdown of academic impact, for papers by Andrei Breazna Breakdown of academic impact, for papers by R. S. Elkeles
Rankless by CCL
2026